Graphene Flagship launches task force to combat COVID-19
This aims to make use of its collective and accumulated knowledge of graphene to fight the current pandemic
This aims to make use of its collective and accumulated knowledge of graphene to fight the current pandemic
CellaVision integration with HORIBA’s HELO automated hematology platform enables unique two-way data flow and rapid results validation
Total antibody test aims to deliver superior clinical performance with 100% sensitivity and 99.8% specificity
Watch this on-demand webinar to learn about the applications for cell-based therapies and biologics using advanced high-throughput flow cytometry
The trial will study the use of ruxolitinib, a JAK inhibitor, to investigate its effect on reducing complications in deteriorating COVID-19 patients
A rare lung disease drug is being trialed to help fight COVID-19
Advance your COVID-19 research with positive and negative SARS-CoV-2 samples
The study is expected to begin enrolling in June with a target of approximately 450 patients globally
Company to make the device available through broad range of healthcare, state, employer and consumer-initiated channels
The RNAdvance Viral XP is a RNA extraction kit validated for use in infectious disease and real-time PCR virus research
Thermo Scientific Orbitrap Exploris 240 mass spectrometer drives discovery and identification with quantitative precision and accuracy to meet customers' specific analytical requirements
The first 4,000 doses have been delivered for use in the Phase 2/3 clinical trial COV002 by the University of Oxford
First patients are expected to be enrolled shortly and additional European regulatory approvals are in process
The platform aims to help researchers generate a clearer view of the current state of research and gain invaluable insights
People who recovered from COVID-19 shows that most individuals had generated antibodies that were intrinsically capable of neutralizing the SARS-CoV-2 virus
Microsemi CRP hematology analyzers have been installed during COVID-19 ‘lockdown’ in POC locations to help reduce hospital admissions
Discover how clinicians at the Center for Personalized Medicine identify and track different coronavirus strains
Register for this webinar to discover how pancreatic cancer-derived organoids can be used as a predictive tool for personalized medicine
Cambridge Cognition has secured over $1.5 million in new contracts to support pharmaceutical clients in delivering virtual clinical trials